Trials / Conditions / Uveal Melanoma, Metastatic

Uveal Melanoma, Metastatic

7 registered clinical trials studyying Uveal Melanoma, Metastatic — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis NCT07203391	St Vincent's Hospital, Sydney	Phase 1
Recruiting	Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma NCT07136181	Novelwise Pharmaceutical Corporation	Phase 1 / Phase 2
Recruiting	A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metas NCT07076550	Alpha-9 Oncology USA Inc.	Phase 1
Active Not Recruiting	Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable NCT06784648	BioInvent International AB	Phase 1 / Phase 2
Unknown	Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal Melanoma NCT05047276	José María Piulats Rodríguez	Phase 1 / Phase 2
Recruiting	Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours NCT04855435	MonTa Biosciences ApS	Phase 1
Active Not Recruiting	PHP and Immunotherapy in Metastasized UM NCT04283890	Leiden University Medical Center	Phase 1 / Phase 2